Regulation of hepcidin and iron-overload disease

Annual Review of Pathology: Mechanisms of Disease

Volumn 4, Issue , 2009, Pages 489-515

  Lee, Pauline L ^a   Beutler, Ernest ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Ferroportin; Hemochromatosis; Hemojuvelin; HFE; TFR2; Transcription

Indexed keywords

BONE MORPHOGENETIC PROTEIN; C REACTIVE PROTEIN; CYTOKINE; ERYTHROPOIETIN; FERROPORTIN; GENE PRODUCT; HEMOJUVELIN; HEPCIDIN; HFE PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; IRON; MATRIPTASE; MATRIPTASE 2; MESSENGER RNA; SMAD1 PROTEIN; SMAD4 PROTEIN; STAT3 PROTEIN; TRANSFERRIN RECEPTOR 2; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; CATION TRANSPORT PROTEIN; HFE2 PROTEIN, HUMAN; MEMBRANE PROTEIN; METAL TRANSPORTING PROTEIN 1;

ANEMIA; CELL STRAIN HEPG2; CHRONIC INFLAMMATION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE MODEL; DOWN REGULATION; ERYTHROPOIESIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC DISORDER; HEMOCHROMATOSIS; HEMOSIDEROSIS; HIGH RISK PATIENT; HOMOZYGOSITY; HORMONE SYNTHESIS; HUMAN; HYPOXIA; INFLAMMATION; IRON ABSORPTION; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON OVERLOAD; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SEX DIFFERENCE; THALASSEMIA; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; CHEMISTRY; GENETIC TRANSCRIPTION; GENETICS; HOMEOSTASIS; METABOLISM; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION;

ANEMIA; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CATION TRANSPORT PROTEINS; HEMOCHROMATOSIS; HOMEOSTASIS; HUMANS; IRON; IRON OVERLOAD; MEMBRANE PROTEINS; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION, GENETIC;

EID: 66149145303     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev.pathol.4.110807.092205     Document Type: Review

References (141)

1. Park CH, Valore EV, Waring AJ, Ganz T. 2001. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 276:7806-7810 (Pubitemid 37385573)
2. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, et al. 2000. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 480:147-150 (Pubitemid 30682492)
3. Bulet P, Stocklin R, Menin L. 2004. Anti-microbial peptides: from invertebrates to vertebrates. Immunol. Rev. 198:169-184
4. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, et al. 2002. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110:1037-1044
5. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. 2003. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101:2461-2463 (Pubitemid 36857598)
6. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, et al. 2001. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276:7811-7819 (Pubitemid 37385574)
7. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, et al. 2001. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. USA 98:8780-8785 (Pubitemid 32678104)
8. Lesbordes-Brion JC, Viatte L, Bennoun M, Lou DQ, Ramey G, et al. 2006. Targeted disruption of the hepcidin1 gene results in severe hemochromatosis. Blood 108:1402-1405 (Pubitemid 44232044)
9. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, et al. 2002. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Natl. Acad. Sci. USA 99:4596-4601 (Pubitemid 34286030)
10. Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, et al. 2003. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33:21-22 (Pubitemid 36068676)
11. Lou DQ, Nicolas G, Lesbordes JC, Viatte L, Grimber G, et al. 2004. Functional differences between hepcidin-1 and -2 in transgenic mice. Blood 103:2816-2821 (Pubitemid 38393044)
12. Nemeth E, Preza GC, Jung CL, Kaplan J, Waring AJ, Ganz T. 2006. The N terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood 107:328-333 (Pubitemid 43053559)
13. De Domenico I, Ward DM, Langelier C, Vaughn MB, Nemeth E, et al. 2007. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol. Biol. Cell 18:2569-2578 (Pubitemid 47025722)
14. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, et al. 2004. Hepcidin regulates ion efflux by binding to ferroportin and inducing its internalization. Science 306:2090-2093 (Pubitemid 40007660)
15. Merryweather-Clarke AT, Cadet E, Bomford A, Capron D, Viprakasit V, et al. 2003. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum. Mol. Genet. 12:2241-2247 (Pubitemid 37098993)
16. Le Gac G, Ferec C. 2005. The molecular genetics of haemochromatosis. Eur. J. Hum. Genet. 13:1172-1185
17. Valore EV, Ganz T. 2008. Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin. Blood Cells Mol. Dis. 40:132-138 (Pubitemid 350192311)
18. Lee P. 2008. Commentary to: Post-translational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin, E Valore, T Ganz. Blood Cells Mol. Dis. 40:139-140 (Pubitemid 350192312)
19. Jacolot S, Le Gac G, Scotet V, Quere I, Mura C, Ferec C. 2004. HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype. Blood 103:2835-2840 (Pubitemid 38393047)
20. Wallace DF, Summerville L, Lusby PE, Subramaniam VN. 2005. Prohepcidin localises to the Golgi compartment and secretory pathway in hepatocytes. J. Hepatol. 43:720-728 (Pubitemid 41253241)
21. Rice WG, Ganz T, Kinkade JM Jr, Selsted ME, Lehrer RI, Parmley RT. 1987. Defensin-rich dense granules of human neutrophils. Blood 70:757-765 (Pubitemid 18027409)
22. Courselaud B, Troadec MB, Fruchon S, Ilyin G, Borot N, et al. 2004. Strain and gender modulate hepatic hepcidin 1 and 2 mRNA expression in mice. Blood Cells Mol. Dis. 32:283-289 (Pubitemid 38296692)
23. Krijt J, Niederkofler V, Salie R, Sefc L, Pelichovska T, et al. 2007. Effect of phlebotomy on hepcidin expression in hemojuvelin-mutant mice. Blood Cells Mol. Dis. 39:92-95 (Pubitemid 46754921)
24. Beutler E, Felitti V, Gelbart T, Ho N. 2000. The effect of HFE genotypes in patients attending a health appraisal clinic. Ann. Intern. Med. 133:329-337
25. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. 2002. Penetrance of the 845G->A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359:211-218 (Pubitemid 34113819)
26. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, et al. 2005. Hemochromatosis and iron-overload screening in a racially diverse population. N. Engl. J. Med. 352:1769-1778 (Pubitemid 40570925)
27. Dullmann J, Wulfhekel U, Mohr A, Riecken K, Hausmann K. 1991. Absence of macrophage and presence of plasmacellular iron storage in the terminal duodenum of patients with hereditary haemochromatosis. Virchows Arch. A Pathol. Anat. Histopathol. 418:241-247
28. Valberg LS, Simon JB, Manley PN, Corbett WE, Ludwig J. 1975. Distribution of storage iron as body iron stores expand in patients with hemochromatosis. J. Lab. Clin. Med. 86:479-489
29. Ross CE, Muir WA, Ng ABP, Graham RC Jr, Kellermeyer RW. 1975. Hemochromatosis. Pathophysiologic and genetic considerations. Am. J. Clin. Pathol. 63:179-191
30. Fillet G, Beguin Y, Baldelli L. 1989. Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation. Blood 74:844-851 (Pubitemid 19208833)
31. Acton RT, Barton JC, Snively BM, McLaren CE, Adams PC, et al. 2006. Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Ethn. Dis. 16:815-821
32. Rochette J, Pointon JJ, Fisher CA, Perera G, Arambepola M, et al. 1999. Multicentric origin of hemochromatosis gene (HFE) mutations. Am. J. Hum. Genet. 64:1056-1062 (Pubitemid 30463036)
33. Pointon JJ, Viprakasit V, Miles KL, Livesey KJ, Steiner M, et al. 2003. Hemochromatosis gene (HFE) mutations in South East Asia: a potential for iron overload. Blood Cells Mol. Dis. 30:302-306 (Pubitemid 36539432)
34. Lee PL, Gelbart T, West C, Halloran C, Beutler E. 2002. Seeking candidate mutations that affect iron homeostasis. Blood Cells Mol. Dis. 29:471-487
35. Nicolas G, Andrews NC, Kahn A, Vaulont S. 2004. Hepcidin, a candidate modifier of the hemochromatosis phenotype in mice. Blood 103:2841-2843 (Pubitemid 38393048)
36. -/- liver and duodenum in mouse strains with differing susceptibilities to iron loading: identification of transcriptional regulatory targets of Hfe and potential hemochromatosis modifiers. Genome Biol. 8:R221
37. (-/-) double knock-out mice. Blood 103:2847-2849
38. Wang F, Paradkar PN, Custodio AO, McVey WD, Fleming MD, et al. 2007. Genetic variation in Mon1a affects protein trafficking and modifies macrophage iron loading in mice. Nat. Genet. 39:1025-1032 (Pubitemid 47185169)
39. Nicolas G, Viatte L, Lou DQ, Bennoun M, Beaumont C, et al. 2003. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat. Genet. 34:97-101 (Pubitemid 36548798)
40. Bridle KR, Frazer DM, Wilkins SJ, Dixon JL, Purdie DM, et al. 2003. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361:669-673
41. Piperno A, Girelli D, Nemeth E, Trombini P, Bozzini C, et al. 2007. Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood 110:4096-4100 (Pubitemid 350248467)
42. Bozzini C, Campostrini N, Trombini P, Nemeth E, Castagna A, et al. 2007. Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. Blood Cells Mol. Dis. 40:347-352
43. Constante M, Jiang WL, Wang DM, Raymond VA, Bilodeau M, Santos MM. 2006. Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 291:G229-37 (Pubitemid 44024682)
44. Frazer DM, Wilkins SJ, Millard KN, McKie AT, Vulpe CD, Anderson GJ. 2004. Increased hepcidin expression and hypoferraemia associated with an acute phase response are not affected by inactivation of HFE. Br. J. Haematol. 126:434-436
45. Lee PL, Peng H, Gelbart T, Beutler E. 2004. The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE, transferrin receptor-2, and β2 microglobulin deficient hepatocytes. Proc. Natl. Acad. Sci. USA 101:9263-9265 (Pubitemid 38812863)
46. Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, et al. 2000. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat. Genet. 25:14-15 (Pubitemid 30257027)
47. Roetto A, Totaro A, Piperno A, Piga A, Longo F, et al. 2001. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 97:2555-2560 (Pubitemid 33785455)
48. Le Gac G, Mons F, Jacolot S, Scotet V, Ferec C, Frebourg T. 2004. Early onset hereditary hemochromatosis resulting from a novel TFR2 gene nonsense mutation (R105X) in two siblings of north French descent. Br. J. Haematol. 125:674-678 (Pubitemid 38747971)
49. Biasiotto G, Camaschella C, Forni GL, Polotti A, Zecchina G, Arosio P. 2008. New TFR2 mutations in young Italian patients with hemochromatosis. Haematologica 93:309-310
50. Majore S, Milano F, Binni F, Stuppia L, Cerrone A, et al. 2006. Homozygous p.M172K mutation of the TFR2 gene in an Italian family with type 3 hereditary hemochromatosis and early onset iron overload. Haematologica 91:ECR33
51. Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C. 2005. Hepcidin is decreased in TFR2 hemochromatosis. Blood 105:1803-1806
52. Fleming RE, Ahmann JR, Migas MC, Waheed A, Koeffler HP, et al. 2002. Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. Proc. Natl. Acad. Sci. USA 99:10653-10658 (Pubitemid 34907032)
53. Kawabata H, Fleming RE, Gui D, Moon SY, Saitoh T, et al. 2005. Expression of hepcidin is downregulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood 105:376-381 (Pubitemid 40053107)
54. Wallace DF, Summerville L, Lusby PE, Subramaniam VN. 2005. First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin. Gut 54:980-986 (Pubitemid 40873913)
55. De Gobbi M, Roetto A, Piperno A, Mariani R, Alberti F, et al. 2002. Natural history of juvenile haemochromatosis. Br. J. Haematol. 117:973-979
56. Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, et al. 2005. Hepcidin in iron overload disorders. Blood 105:4103-4105
57. Lee P, Promrat K, Mallette C, Flynn M, Beutler E. 2006. Juvenile hemochromatosis patient homozygous for a novel deletion of cDNA nucleotide 81 of hemojuvelin. Acta Haematol. (Basel ) 115:123-127 (Pubitemid 43130446)
58. Murugan RC, Lee PL, Kalavar M, Barton JC. 2008. Early age-of-onset iron overload and homozygosity for the novel hemojuvelin mutation HJV R54X (eon 3; c.160A->T) in an African American male of West Indies descent. Clin. Genet. 74:88-92 (Pubitemid 351833824)
59. Lee PL, Beutler E, Rao SV, Barton JC. 2004. Genetic abnormalities and juvenile hemochromatosis mutations of the HJV gene encoding hemojuvelin. Blood 103:4669-4671 (Pubitemid 38746001)
60. Wallace DF, Dixon JL, Ramm GA, Anderson CJ, Powell LW, Subramaniam N. 2005. Hemojuvelin (HJV)-associated hemochromatosis: analysis of HJV and HFE mutations and iron overload in three families. Haematologica 90:254-255 (Pubitemid 40293289)
61. Lanzara C, Roetto A, Daraio F, Rivard S, Ficarella R, et al. 2004. The spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood 103:4317-4321 (Pubitemid 38685379)
62. Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, et al. 2004. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat. Genet. 36:77-82 (Pubitemid 38056211)
63. Daraio F, Ryan E, Gleeson F, Roetto A, Crowe J, Camaschella C. 2005. Juvenile hemochromatosis due to G320V/Q116X compound heterozygosity of hemojuvelin in an Irish patient. Blood Cells Mol. Dis. 35:174-176 (Pubitemid 41267046)
64. Gehrke S, Pietrangelo A, Kascak M, Braner A, Eisold M, et al. 2005. HJV gene mutations in European patients with juvenile hemochromatosis. Clin. Genet. 67:425-428 (Pubitemid 40561493)
65. Ka C, Le GG, Letocart E, Gourlaouen I, Martin B, Ferec C. 2007. Phenotypic and functional data confirm causality of the recently identified hemojuvelin p.r176c missense mutation. Haematologica 92:1262-1263 (Pubitemid 350144189)
66. Goldschmidt H, Spiera H, Schumacher HR Jr, Zaroulis CG. 1987. Idiopathic hemochromatosis presenting as amenorrhea and arthritis. Am. J. Med. 82:1057-1059 (Pubitemid 18131357)
67. Koyama C, Hayashi H, Wakusawa S, Ueno T, Yano M, et al. 2005. Three patients with middle-age-onset hemochromatosis caused by novel mutations in the hemojuvelin gene. J. Hepatol. 43:740-742 (Pubitemid 41253245)
68. Filali M, Le Jeunne C, Durand E, Grinda JM, Roetto A, et al. 2004. Juvenile hemochromatosis HJV-related revealed by cardiogenic shock. Blood Cells Mol. Dis. 33:120-124 (Pubitemid 39094718)
69. Rivard SR, Mura C, Simard H, Simard R, Grimard D, et al. 2000. Clinical and molecular aspects of juvenile hemochromatosis in Saguenay-Lac-Saint-Jean (Quebec, Canada). Blood Cells Mol. Dis. 26:10-14 (Pubitemid 30331766)
70. Aguilar-Martinez P, Lok CY, Cunat S, Cadet E, Robson K, Rochette J. 2007. Juvenile hemochromatosis caused by a novel combination of hemojuvelin G320V/R176C mutations in a 5-year old girl. Haematologica 92:421-422 (Pubitemid 350143556)
71. Lee PL, Barton JC, Brandhagen D, Beutler E. 2004. Hemojuvelin (HJV ) mutations in persons of European, African-American and Asian ancestry with adult onset haemochromatosis. Br. J. Haematol. 127:224-229 (Pubitemid 39371818)
72. Huang FW, Rubio-Aliaga I, Kushner JP, Andrews NC, Fleming MD. 2004. Identification of a novel mutation (C321X) in HJV. Blood 104:2176-2177 (Pubitemid 39297874)
73. Silvestri L, Pagani A, Fazi C, Gerardi G, Levi S, et al. 2007. Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis. Blood 109:4503-4510 (Pubitemid 46743421)
74. Huang FW, Pinkus JL, Pinkus GS, Fleming MD, Andrews NC. 2005. A mouse model of juvenile hemochromatosis. J. Clin. Invest. 115:2187-2191
75. Niederkofler V, Salie R, Arber S. 2005. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J. Clin. Invest. 115:2180-2186 (Pubitemid 41134159)
76. Rideau A, Mangeat B, Matthes T, Trono D, Beris P. 2007. Molecular mechanism of hepcidin deficiency in a patient with juvenile hemochromatosis. Haematologica 92:127-128 (Pubitemid 46232668)
77. Matthes T, Aguilar-Martinez P, Pizzi-Bosman L, Darbellay R, Rubbia-Brandt L, et al. 2004. Severe hemochromatosis in a Portuguese family associated with a new mutation in the 5′ UTR of the HAMP gene. Blood 104:2181-2183 (Pubitemid 39297876)
78. Delatycki M, Allen K, Gow P, MacFarlane J, Radomski C, et al. 2004. A homozygous HAMP mutation in a multiply consanguineous family with pseudodominant juvenile hemochromatosis. Clin. Genet. 65:378-383 (Pubitemid 38659706)
79. (-/-) mice is not impairing glucose homeostasis. FEBS Lett. 581:1053-1057
80. Pietrangelo A. 2004. The ferroportin disease. Blood Cells Mol. Dis. 32:131-138
81. Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, et al. 2001. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J. Clin. Invest. 108:619-623 (Pubitemid 32777742)
82. Njajou OT, Vaessen N, Joosse M, Berghuis B, van Dongen JW, et al. 2001. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat. Genet. 28:213-214 (Pubitemid 32626019)
83. De Domenico I, McVey WD, Musci G, Kaplan J. 2006. Iron overload due to mutations in ferroportin. Haematologica 91:92-95 (Pubitemid 43235391)
84. Drakesmith H, Schimanski LM, Ormerod E, Merryweather-Clarke AT, Viprakasit V, et al. 2005. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 106:1092-1097 (Pubitemid 41076459)
85. Sham RL, Phatak PD, West C, Lee PL, Andrews C, Beutler E. 2005. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features. Blood Cells Mol. Dis. 34:157-161 (Pubitemid 40250491)
86. Barton JC, Acton RT, Lee PL, West C. 2007. SLC40A1 Q248Hallele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descent. Blood Cells Mol. Dis. 39:206-211 (Pubitemid 47161131)
87. Beutler E, Barton JC, Felitti VJ, Gelbart T, West C, et al. 2003. Ferroportin (SCL40A1) variant associated with iron overload in African-Americans. Blood Cells Mol. Dis. 31:305-309 (Pubitemid 37441302)
88. Gordeuk VR, Caleffi A, Corradini E, Ferrara F, Jones RA, et al. 2003. Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. Blood Cells Mol. Dis. 31:299-304 (Pubitemid 37433868)
89. Zohn IE, De Domenico I, Pollock A, Ward DM, Goodman JF, et al. 2007. The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease. Blood 109:4174-4180 (Pubitemid 46743381)
90. Mok H, Jelinek J, Pai S, Cattanach BM, Prchal JT, et al. 2004. Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice. Development 131:1859-1868 (Pubitemid 38559852)
91. Mok H, Mendoza M, Prchal JT, Balogh P, Schumacher A. 2004. Dysregulation of ferroportin 1 interferes with spleen organogenesis in polycythaemia mice. Development 131:4871-4881 (Pubitemid 39433472)
92. Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D. 2005. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106:1864-1866 (Pubitemid 41208606)
93. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, et al. 2004. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113:1271-1276 (Pubitemid 39069926)
94. Rivera S, Liu L, Nemeth E, Gabayan V, Sorensen OE, Ganz T. 2005. Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia. Blood 105:1797-1802 (Pubitemid 40223704)
95. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. 2002. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100:3776-3781
96. Ganz T. 2002. The role of hepcidin in iron sequestration during infections and in the pathogenesis of anemia of chronic disease. Isr. Med. Assoc. J. 4:1043-1045
97. Andrews NC. 2004. Anemia of inflammation: the cytokine-hepcidin link. J. Clin. Invest. 113:1251-1253
98. van der PK, Braam B, Jie KE, Gaillard CA. 2008. Mechanisms of disease: erythropoietin resistance in patients with both heart and kidney failure. Nat. Clin. Pract. Nephrol. 4:47-57
99. Balla J, Jeney V, Varga Z, Komodi E, Nagy E, Balla G. 2007. Iron homeostasis in chronic inflammation. Acta Physiol. Hung. 94:95-106
100. Semrin G, Fishman DS, Bousvaros A, Zholudev A, Saunders AC, et al. 2006. Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm. Bowel. Dis. 12:1101-1106 (Pubitemid 44847466)
101. Pootrakul P, Kitcharoen K, Yansukon P, Wasi P, Fucharoen S, et al. 1988. The effect of erythroid hyperplasia on iron balance. Blood 71:1124-1129 (Pubitemid 18111156)
102. Weatherall DJ. 2006. Disorders of globin synthesis: The thalassemias. In Williams Hematology, ed. MA Lichtman, E Beutler, TJ Kipps, U Seligsohn, K Kaushansky, J Prchal, pp. 633-666 New York: McGraw-Hill
103. Tanno T, Bhanu NV, O'Neal PA, Goh SH, Staker P, et al. 2007. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat. Med. 13:1096-1101 (Pubitemid 47517510)
104. Hsiao EC, Koniaris LG, Zimmers-Koniaris T, Sebald SM, Huynh TV, Lee SJ. 2000. Characterization of growth-differentiation factor 15, a transforming growth factor β superfamily member induced following liver injury. Mol. Cell Biol. 20:3742-3751 (Pubitemid 30243919)
105. Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, et al. 2007. Liver iron concentrations and urinary hepcidin in β-thalassemia. Haematologica 92:583-588 (Pubitemid 350144260)
106. De FL, Daraio F, Filippini A, Carturan S, Muchitsch EM, et al. 2006. Liver expression of hepcidin and other iron genes in two mouse models of β-thalassemia. Haematologica 91:1336-1342 (Pubitemid 44569806)
107. Wrighting DM, Andrews NC. 2006. Interleukin-6 induces hepcidin expression through STAT3. Blood 108:3204-3209
108. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, et al. 2006. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat. Genet. 38:531-539
109. Zhang AS, Anderson SA, Meyers KR, Hernandez C, Eisenstein RS, Enns CA. 2007. Evidence that inhibition of hemojuvelin shedding in response to iron is mediated through neogenin. J. Biol. Chem. 282:12547-12556 (Pubitemid 47100643)
110. Kuninger D, Kuns-Hashimoto R, Kuzmickas R, Rotwein P. 2006. Complex biosynthesis of the muscle-enriched iron regulator RGMc. J. Cell Sci. 119:3273-3283 (Pubitemid 44405213)
111. Babitt JL, Zhang Y, Samad TA, Xia Y, Tang J, et al. 2005. Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein coreceptor. J. Biol. Chem. 280:29820-29827 (Pubitemid 41177060)
112. Huang FW, Babitt JL, Wrighting DM, Samad TA, Xia Y, et al. 2005. Hemojuvelin acts as a bone morphogenetic protein co-receptor to regulate hepcidin. Blood 106:153a (Pubitemid 41177060)
113. Wang RH, Li CL, Xu XL, Zheng Y, Xiao CY, et al. 2005. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metabolism 2:399-409
114. Lin L, Goldberg YP, Ganz T. 2005. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood 106:2884-2889 (Pubitemid 41510769)
115. Lin L, Nemeth E, Goodnough JB, Thapa DR, Gabayan V, Ganz T. 2008. Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site. Blood Cells Mol. Dis. 40:122-131 (Pubitemid 350193320)
116. Silvestri L, Pagani A, Camaschella C. 2008. Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood 111:924-931
117. Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, Lin HY. 2007. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J. Clin. Invest. 117:1933-1939 (Pubitemid 47036327)
118. Truksa J, Peng H, Gelbart T, Lee P, Beutler E. 2006. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc. Natl. Acad. Sci. USA 103:10289-10293 (Pubitemid 44051159)
119. Lin L, Nemeth E, Goodnough JB, Thapa DR, Gabayan V, Ganz T. 2007. Iron-transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood 110:2182-2189 (Pubitemid 47443938)
120. Truksa J, Peng H, Lee P, Beutler E. 2007. Different regulatory elements are required for response of hepcidin to IL-6 and bone morphogenetic proteins BMP 4 and 9. Br. J. Haematol. 139:138-147 (Pubitemid 47389916)
121. Courselaud B, Pigeon C, Inoue Y, Inoue J, Gonzalez FJ, et al. 2002. C/EBPα regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J. Biol. Chem. 277:41163-41170 (Pubitemid 35215708)
122. Gehrke SG, Kulaksiz H, Herrmann T, Riedel HD, Bents K, et al. 2003. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to serum transferrin saturation and nontransferrin-bound iron. Blood 102:371-376 (Pubitemid 36759679)
123. Johnson MB, Enns CA. 2004. Diferric transferrin regulates transferrin receptor 2 protein stability. Blood 104:4287-4293 (Pubitemid 39620184)
124. Robb A, Wessling-Resnick M. 2004. Regulation of transferrin receptor 2 protein levels by transferrin. Blood 104:4294-4299 (Pubitemid 39620185)
125. Goswami T, Andrews NC. 2006. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J. Biol. Chem. 281:28494-28498 (Pubitemid 44506991)
126. Johnson MB, Chen J, Murchison N, Green FA, Enns CA. 2007. Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway. Mol. Biol. Cell 18:743-754 (Pubitemid 46399482)
127. Chen J, Chloupkova M, Gao J, Chapman-Arvedson TL, Enns CA. 2007. HFE modulates transferrin receptor 2 levels in hepatoma cells via interactions that differ from transferrin receptor 1/HFE interactions. J. Biol. Chem. 282:36862-36870
128. Flanagan J, Truksa J, Peng H, Lee P, Beutler E. 2006. Investigation of the iron responsive elements of the hepcidin promoter by in vivo imaging of mice. Blood 108:442a
129. Truksa J, Lee P, Peng H, Flanagan J, Beutler E. 2007. The distal location of the iron responsive region of the hepcidin promoter. Blood 110:3436-3437 (Pubitemid 350106339)
130. Nicolas G, Viatte L, Bennoun M, Beaumont C, Kahn A, Vaulont S. 2002. Hepcidin, a new iron regulatory peptide. Blood Cells Mol. Dis. 29:327-335
131. Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. 2006. Suppression of hepcidin during anemia requires erythropoietic activity. Blood 108:3730-3735 (Pubitemid 44864551)
132. Vokurka M, Krijt J, Sulc K, Necas E. 2006. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol. Res. 55:667-674 (Pubitemid 46021227)
133. Byrd RB, Cooper T. 1961. Hereditary iron-loading anemia with secondary hemochromatosis. Ann. Intern. Med. 55:103-123
134. Kattamis A, Papassotiriou I, Palaiologou D, Apostolakou F, Galani A, et al. 2006. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major. Haematologica 91:809-812 (Pubitemid 44014549)
135. Krijt J, Vokurka M, Chang KT, Necas E. 2004. Expression of Rgmc, the murine ortholog of hemojuvelin gene, is modulated by development and inflammation, but not by iron status or erythropoietin. Blood 104:4308-4310 (Pubitemid 39620187)
136. Sun XF, Zhou DB, Zhao YQ. 2006. An iron regulator hepcidin is affected by EPO. Zhongguo Shi Yan Xue Ye Xue Za Zhi 14:778-782
137. Flanagan JM, Peng H, Lee PL, Beutler E. 2005. Analysis of the effect of soluble transferrin receptor 1 (sTfR1) on iron metabolism in mice. Blood 106:999a
138. Choi SO, Cho YS, Kim HL, Park JW. 2007. ROS mediate the hypoxic repression of the hepcidin gene by inhibiting C/EBPα and STAT-3. Biochem. Biophys. Res. Commun. 356:312-317
139. Semenza GL. 2007. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE. 407:cm8
140. Peyssonnaux C, Zinkernagel AS, Schuepbach RA, Rankin E, Vaulont S, et al. 2007. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J. Clin. Invest. 117:1926-1932 (Pubitemid 47036326)
141. Du X, She E, Gelbart T, Truksa J, Lee P, et al. 2008. The serine protease TMPRSS6 is required to sense iron deficiency. Science 320:1088-1092 (Pubitemid 351929552)